This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Aimée Dymphne Catherine Paulussen: Innovator in Genotyping Cytochrome Expression
Introduction
Aimée Dymphne Catherine Paulussen is a notable inventor based in Tilburg, Netherlands. He has made significant contributions to the field of pharmacogenomics, particularly in understanding drug metabolism through genetic variations.
Latest Patents
Aimée holds a patent for a method titled "Genotyping Cytochrome Expression." This innovative method identifies subjects with high or low drug metabolizing phenotypes associated with cytochrome CYP3A5 expression. The process involves screening genomic DNA from subjects for the presence or absence of polymorphic variants in a transcription regulatory region of the CYP3A5 encoding sequence. Additionally, oligonucleotide molecules for carrying out the screening are provided in the patent. Aimée has 1 patent to his name.
Career Highlights
Aimée is currently employed at Janssen Pharmaceutica, a leading pharmaceutical company known for its commitment to innovation in healthcare. His work focuses on enhancing the understanding of drug metabolism, which is crucial for personalized medicine.
Collaborations
Aimée collaborates with various professionals in the field, including his coworker Martin Armstrong, to advance research and development in pharmacogenomics.
Conclusion
Aimée Dymphne Catherine Paulussen's contributions to the field of drug metabolism through his innovative patent highlight his role as a key figure in pharmacogenomics. His work at Janssen Pharmaceutica continues to pave the way for advancements in personalized medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile